The Benefit Of A “Light Touch” In Identifying Melanoma In Natalizumab Treated Patients- A Southern Network On Adverse Reactions (Sonar) Analysis Based On The Tysabri Outreach Commitment To Health Registry (Touch)
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1630
https://www.valueinhealthjournal.com/article/S1098-3015(16)01698-3/fulltext
Title :
The Benefit Of A “Light Touch” In Identifying Melanoma In Natalizumab Treated Patients- A Southern Network On Adverse Reactions (Sonar) Analysis Based On The Tysabri Outreach Commitment To Health Registry (Touch)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01698-3&doi=10.1016/j.jval.2016.03.1630
First page :
A134
Section Title :
Cancer - Clinical Outcomes Studies
Open access? :
No
Section Order :
218